Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study has identified that NHS infant checks can miss serious hip abnormalities in new-born babies. Left undetected, these can require complex surgery, and lead to early arthritis. In the UK around 500 infants undergo surgery for dislocated hips which could have been avoidable.

Baby having hips checked

 

A collaboration between the University of Oxford and University of Leeds, it shows that the tests currently used by doctors can be unreliable. Using data on 27,000 babies, their research, published in JAMA, found the best tests miss over half of abnormal hips – and indicates that for every 1000 hips screened, 4 dislocations will be identified, but 5 will be missed.

Developmental dysplasia of the hip (DDH) is a condition where the "ball and socket" joint of the hip does not properly form in babies and young children. DDH is one of the most common musculoskeletal conditions in infants and around 1 in every 100 babies are born with the ball of the hip bone dislocated from the socket.

If a dislocated hip is diagnosed early, it can usually be treated with a removable brace that the baby wears over their clothes for a couple of months. However, delayed diagnosis often requires complex surgery, and can lead to early arthritis requiring a hip replacement when the children become young adults.

The NHS baby hip screening checks involve several clinical tests, performed within 72 hours of birth and again between 6-8 weeks. However, researchers highlight there has been some doubt concerning the reliability of these tests, so the study set out to evaluate the diagnostic accuracy of clinical examination in identifying dislocated hips in infants.

Professor Daniel Perry, NIHR Professor at the University of Liverpool and a children's orthopaedic surgeon at Alder Hey Children's Hospital said: 'Doctors have known for some time that there are challenges with the newborn hip examination and this study confirms the problem. What brings additional concern is that all hip examinations in this study were conducted by experts in hip disease – which is not usually the case in the NHS – so the true problem may be bigger. Nevertheless, we're determined to make things better.

'NHS England has recently started working with the National Institute for Health and Care Research (NIHR) to begin research to improve hip screening amongst babies. Earlier this month NHS England launched a change in the hip screening pathway for babies, which will enable the UK to be world leaders in research this area. We hope that this could soon mean new tests on the hips of babies, such as artificial intelligence enabled ultrasound. It's heartening to see a new collaboration between NHS England and NIHR which I hope will translate into better care for children and young people.'

Dr Abhinav Singh, Orthopaedic Surgeon and Researcher at NDORMS said: 'It is important that doctors are well trained in the hip examination and know which tests can help identify hip abnormalities. However, our findings clearly highlight that examining babies' hips will not identify all dislocations. Emphasising certain examination manoeuvres that can assist in early diagnosis of DDH is of clear benefit to infants, their families and the clinician, but our results also provide evidence of the fallibility of the examination.'

The study pooled data from 50, 579 hip joints in 27, 175 infants examined between 1992 to 2021 in screening programmes run by experts. Statistical models were used to calculate the sensitivity, specificity and likelihood ratios of different examination manoeuvres in identifying a dislocated hip in infants aged 3 months or younger.
While useful in some children, researchers identified that the clinical examination missed more dislocated hips than it was able to identify. The only part of the test that the authors identified to be useful is called the 'Barlow/Ortolani manoeuvre'. The authors concluded that other parts of the test, including limited hip abduction and a clicking sound had no clear diagnostic utility.

This research was funded by the National Institute for Health and Care Research (NIHR), the research partner of the NHS, public health and social care. It was supported by the NIHR Oxford Biomedical Research Centre.

Similar stories

NDORMS researchers win prestigious national leadership prizes

Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contribution to health and care research.

From Paraguay to Oxford: Mariela’s experience of the Trueta Bursary

Mariela Ortiz, a pharmacist from Paraguay received a Trueta Bursary to attend the Botnar Institute's Summer School in Real World Evidence this June.

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

NDORMS student wins national research prize

A medical student at NDORMS has gained a top prize in the prestigious 2026 Falk Foundation/Guts UK Charity national awards. Sara Lyden won the Medical Student Prize for her research project, ‘Integrating histo-molecular patient profiles with patient reported symptoms and quality of life measures in ulcerative colitis.’

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.

NDORMS team wins Award for Excellence for transforming ulcerative colitis care

The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.